Eaze Brings Weed to Medical Users

 

SAN FRANCISCOEaze, a delivery service for medical marijuana, has completed a $13 million Series B financing round. The investment makes Eaze the fastest growing and most funded cannabis technology company in the world. It has now raised more than $25 million in total funding. Fresh VC led the round with participation from DCM Ventures, Tusk Ventures, Winklevoss Capital, Rose Capital and others.

Eaze remains committed to providing the best patient experience and will use the latest financing to accelerate product innovation, grow its world-class team, and expand its technology to additional markets. The financing comes at a time when sentiment towards marijuana have shifted in light of increasing public acceptance of marijuana for medical and adult use. Nine states have legislation relating to legalizing aspects of marijuana use on the ballot this November.

“This is a critical time for the marijuana industry. Adult use is on the precipice of becoming legal in California, the largest marijuana market in the United States. Eaze is setting a new standard for accessibility, safety, and professionalism, which makes it best positioned to educate and service the future market,” said Keith McCarty, CEO of Eaze. “We’re thrilled with the growth we’ve achieved and are poised to accelerate as the market hits an inflection point.”

Since launching in July 2014, Eaze technology has powered on-demand dispensary deliveries to hundreds of thousands of medical marijuana patients in nearly 100 California cities. Eaze technology connects patients with dispensaries, and provides logistics technology that enables dispensaries to deliver in less than 20 minutes. For patients in need of a medical marijuana recommendation, EazeMD connects California residents with board-certified doctors to receive an evaluation on demand through its mobile and online platforms.